Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice.
There is a desperate need for effective therapies to fight chronic viral infections. The immune response is normally fastidious at controlling the majority of viral infections and a therapeutic strategy aimed at reestablishing immune control represents a potentially powerful approach towards treatin...
Main Authors: | Scott G Kitchen, Michael Bennett, Zoran Galić, Joanne Kim, Qing Xu, Alan Young, Alexis Lieberman, Aviva Joseph, Harris Goldstein, Hwee Ng, Otto Yang, Jerome A Zack |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-12-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2785433?pdf=render |
Similar Items
-
In vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells.
by: Scott G Kitchen, et al.
Published: (2012-01-01) -
Hematopoietic Stem Cell Transplantation for Primary Immunodeficiencies
by: Andrew R. Gennery, et al.
Published: (2019-10-01) -
Primary Immunodeficiency Diseases and Hematopoietic Stem Cell Transplantation
by: Ayse Ozkan
Published: (2014-02-01) -
Hematopoietic Stem Cell Transplantation for Severe Combined Immunodeficiency (SCID)
by: Elie Haddad, et al.
Published: (2019-11-01) -
Mismatched related hematopoietic stem cell transplantation in primary immunodeficiency
by: Adel M Wahadneh, et al.
Published: (2013-01-01)